The value of the ratio of free-to-total prostate specific antigen for staging purposes in previously untreated prostate cancer

Journal of Urology

Volumn 159, Issue 6, 1998, Pages 2004-2008

  Noldus, Joachim ^a   Graefen, Markus ^a   Huland, Edith ^a   Busch, Christopher ^a   Hammerer, Peter ^a   Huland, Hartwig ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Prostate; Prostate specific antigen; Prostatic neoplasms

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ARTICLE; CANCER GRADING; CANCER STAGING; DIAGNOSTIC VALUE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY;

EID: 0032436184     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)63227-0     Document Type: Article

References (23)

1. Stamey, T. A., Yang, N., Hay, A. R., McNeal, J. E., Freiha, F. S. and Redwine, E.: Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. New Engl. J. Med., 317: 909, 1987.
2. Oesterling, J. E., Chan, D. W., Epstein, J. I., Kimball, A. W., Jr., Bruzek, D. J., Rock, R. C., Brendler, C. B. and Walsh, P. C.: Prostate specific antigen in the preoperative and postoperative evaluation of localized prostate cancer treated with radical prostatectomy. J. Urol., 139: 766, 1988.
3. Stamey, T. A. and Kabalin, J. N.: Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. I. Untreated patients. J. Urol., 141: 1070, 1989.
4. Partin, A. W., Carter, H. B., Chan, D. W., Epstein, J. I., Oesterling, J. E., Rock, R. C., Weber, J. P. and Walsh, P. C.: Prostate specific antigen in the staging of localized prostate cancer: influence of tumor differentiation, tumor volume and benign hyperplasia. J. Urol., 143: 747, 1990.
5. Noldus, J. and Stamey, T. A.: Limitations of serum prostate specific antigen in predicting peripheral and transition zone cancer volumes as measured by correlation coefficients. J. Urol., 155: 232, 1996.
6. Lilja, H., Christensson, A., Dahlen, U., Matikainen, M.-T., Nilsson, O., Pettersson, K. and Lövgren, T.: Prostate-specific antigen in human serum occurs predominantly in complex with α-1-antichymotrypsin. Clin. Chem., 37: 1618, 1991.
7. Stenman, U. H., Leinonen, J., Alfthan, H., Rannikko, S., Tuhkanen, K. and Alfthan, O.: A complex between prostate-specific antigen and alpha-1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer: assay of the complex improves clinical sensitivity for cancer. Cancer Res., 51: 222, 1991.
8. Christensson, A., Björk, T., Nilsson, O., Dahlen, U., Matikainen, M.-T., Cockett, A. T. K., Abrahamsson, P. and Lilja, H.: Serum prostate specific antigen complexed to α-1-antichymotrypsin as an indicator of prostate cancer. J. Urol., 150: 100, 1993.
9. Stamey, T. A., Chen, Z. and Prestigiacomo, A.: Serum prostate specific antigen binding α1-antichymotrypsin: influence of cancer volume, location and therapeutic selection of resistant clones. J. Urol., 152: 1510, 1994.
10. Catalona, W. J., Smith, D. S., Wolfert, R. L., Wang, T. J., Rittenhouse, H. G., Ratliff T. L. and Nadler, R. B.: Evaluation of percentage of free serum prostate-specific antigen to improve specificity of prostate cancer screening. J.A.M.A., 274: 1214, 1995.
11. Luderer, A. A., Chen, Y.-T., Soriano, T. F., Kramp, W. J., Carlson, G., Cuny, C., Sharp, T., Smith, W., Petteway, J., Brawer, M. K. and Thiel, R.: Measurement of the proportion of free to total prostate-specific antigen improves diagnostic performance of prostate-specific antigen in the diagnostic gray zone of total prostate-specific antigen. Urology, 46: 187, 1995.
12. Prestigiacomo, A. F., Lilja, H., Pettersson, K., Wolfert, R. L. and Stamey, T. A.: A comparison of the free fraction of serum prostate specific antigen in men with benign and cancerous prostates: the best case scenario. J. Urol., 156 350: 1996.
13. Lerner, S. E., Jacobsen, S. J., Lilja, H., Bergstralh, E. J., Ransom, J., Klee, G. G., Piironen, T., Blute, M. L., Lieber, M. M., Zincke, H., Pettersson, K., Peterson, D. and Oesterling, J. E.: Free, complexed, and total serum prostate-specific antigen concentrations and their proportions in predicting stage, grade, and deoxyribonucleic acid ploidy in patients with adenocarcinoma of the prostate. Urology, 48: 240, 1996.
14. Graefen, M., Hammerer, P., Henke, P., Hilz, H., Huland, E. and Huland, H.: Percentage of free PSA does not correlate with pathological outcome. J. Urol., part 2, 155: A370, abstact 237, 1996.
15. Bangma, C. H., Kranse, R., Blijenberg, B. G. and Schröder, F. H.: The free-to-total serum prostate specific antigen ratio for staging prostate carcinoma. J. Urol., 157: 544, 1997.
16. Pannek, J., Subong, E. N., Jones, K. A., Marschke, P. L., Epstein, J. I., Chan, D. W., Carter, H. B., Luderer, A. A. and Partin, A. W.: The role of free/total prostate-specific antigen ratio in the prediction of final pathologic stage for men with clinically localized prostate cancer. Urology, 48: 51, 1996.
17. McNeal, J. E., Villers, A. A., Redwine, E. A., Freiha, F. S. and Stamey, T. A.: Histologic differentiation, cancer volume, and pelvic lymph node metastasis in adenocarcinoma of the prostate. Cancer, 66: 1225, 1990.
18. Gleason, D. F.: Histologic grading and clinical staging of prostatic carcinoma. In: Urologic Pathology: The Prostate. Edited by M. Tannenbaum. Philadelphia: Lea & Febiger, chapt. 9, pp. 171-197, 1977.
19. Stamey, T. A., Kabalin, J. N., McNeal, J. E., Johnstone, I. M., Freiha, R., Redwine, E. A. and Yang, N.: Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. II. Radical prostatectomy treated patients. J. Urol., 141: 1076, 1989.
20. Partin, A. W., Yoo, J., Carter, H. B., Pearson, J. D., Chan, D. W., Epstein, J. I. and Walsh, P. C.: The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer. J. Urol., 150: 110, 1993.
21. Blackwell, K. L., Bostwick, D. G., Myers, R. P., Zincke, H. and Oesterling, J. E.: Combining prostate specific antigen with cancer and gland volume to predict more reliably pathological stage: the influence of prostate specific antigen cancer density. J. Urol., 151: 1565, 1994.
22. Bjartell, A., Björk, T., Matikainen, M. T., Abrahamsson, P. A., di Sant'Agnese, A. and Lilja, H.: Production of alpha-1-antichymotrypsin by PSA-containing cells of the human prostate epithelium. Urology, 42: 502, 1993.
23. Björk, T., Bjartell, A., Abrahamsson, P. A., Hulkko, S., di Sant'Agnese, A. and Lilja, H.: Alpha-1-antichymotrypsin production in PSA-producing cells is common in prostate cancer but rare in benign prostatic hyperplasia. Urology, 43: 427, 1994